Casgevy, a world-first CRISPR-based gene therapy, aims to cure sickle cell anemia
Signals Blog,
I can recall the first time that I heard about the idea of gene therapy. It was over 20 years ago, and possibly like many…
I can recall the first time that I heard about the idea of gene therapy. It was over 20 years ago, and possibly like many…
THURSDAY, July 20, 2023 (HealthDay News) — Globally, sickle cell disease provides a high contribution to all-cause mortality…
Reducing the burden of Sickle Cell Disease (SCD) requires substantial financial and political commitment to improving data-collec…
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from…